cellular
metabol
fundament
complex
biolog
phenomenon
consist
two
opposit
entwin
process
catabol
break
macromolecul
produc
energi
form
adenosin
triphosph
atp
fuel
cellular
reaction
event
anabol
deliv
nutrient
carbohydr
amino
acid
fatti
acid
macromolecular
synthesi
fine
balanc
catabol
anabol
pathway
critic
meet
divers
biolog
demand
thu
allow
organ
respond
activ
dynam
environ
abnorm
metabol
state
hallmark
neurolog
disord
diabet
obes
cancer
increasingli
evid
viral
infect
rewir
metabol
host
cell
advantag
viral
propag
leav
metabol
footprint
caus
metabol
diseas
turn
respond
contain
viral
infect
host
particular
immun
cell
need
select
mobil
deploy
metabol
resourc
order
mount
effect
innat
adapt
immun
respons
focu
review
well
receiv
immun
cell
need
adopt
distinct
metabol
profil
achiev
activ
differenti
effector
function
sever
articl
detail
signific
metabol
signatur
immun
cell
macrophag
dendrit
cell
tcell
upon
activ
earli
studi
indic
chang
metabol
toward
aerob
glycolysi
lipopolysaccharid
lp
activ
macrophag
requir
produc
proinflammatori
cytokin
metabol
signatur
also
appar
cell
elev
level
aerob
glycolysi
maintain
effector
cell
subset
respons
cytokin
particular
proinflammatori
lymphocyt
heavili
depend
glycolysi
differenti
glycolysi
block
differenti
surviv
impair
antiinflammatori
phenotyp
favor
importantli
shift
aerob
glycolysi
allow
immun
cell
adapt
surviv
acquir
effector
function
metabol
limit
condit
infect
hypoxia
review
focu
discuss
metabol
interplay
virus
innat
immun
respons
occur
earli
stage
viral
infect
host
illumin
known
variou
virus
modul
cellular
metabol
distinct
mechan
cell
respons
viral
infect
produc
interferon
alter
specif
metabol
pathway
one
effect
strategi
control
viral
replic
virus
complet
depend
host
cellular
metabol
fuel
product
viral
progeni
effect
virus
cellular
metabol
alreadi
describ
studi
observ
addit
glucos
minim
media
significantli
increas
yield
poliovirus
infect
hela
cell
howev
detail
understand
subject
consider
acceler
applic
mass
spectrometri
measur
mani
metabolit
concurr
well
possibl
track
carbon
flux
use
isotop
label
carbon
sourc
includ
glucos
glutamin
extens
metabol
studi
perform
varieti
virus
includ
dengu
viru
human
herpesviru
type
hepat
c
viru
hcv
vaccinia
viru
human
immunodefici
viru
type
influenza
viru
iav
human
cytomegaloviru
hcmv
herp
simplex
result
reveal
three
core
metabol
pathway
glycolysi
fatti
acid
synthesi
glutaminolysi
commonli
alter
almost
virus
use
distinct
mechan
facilit
discret
step
viral
propag
well
sustain
latent
infect
cell
glycolysi
multipl
step
process
convert
glucos
pyruv
concurr
product
reduct
two
nicotinamid
adenin
dinucleotid
nad
nadh
figur
normal
nonprolifer
cell
expos
oxygen
pyruv
enter
mitochondria
oxid
acetyl
coenzym
coa
coa
feed
tricarboxyl
tca
cycl
also
known
citric
acid
kreb
cycl
drive
electron
transport
chain
gener
atp
adenosin
diphosph
call
oxid
phosphoryl
complet
metabol
carbon
dioxid
tca
cycl
one
glucos
gener
atp
equival
lack
oxygen
addit
enter
tca
cycl
pyruv
also
reduc
lactat
type
glycolysi
also
occur
presenc
suffici
oxygen
tumor
cell
process
call
aerob
glycolysi
warburg
effect
first
describ
otto
warburg
known
viral
infect
caus
shift
aerob
glycolysi
gener
rapid
sourc
atp
also
use
abund
metabol
intermedi
presenc
reduc
tca
cycl
acceler
synthesi
nucleotid
amino
acid
fatti
acid
need
assembl
larg
number
viral
progeni
rel
short
time
span
glutamin
second
carbon
sourc
process
call
glutaminolysi
glutamin
metabol
alpha
ketoglutar
enter
tca
cycl
gener
atp
figur
virus
use
carbon
sourc
other
vaccinia
viru
prefer
use
glutamin
addit
fatti
acid
also
serv
import
energi
sourc
oxid
mitochondria
produc
coa
drive
tca
cycl
virus
appear
evolv
plethora
mechan
modul
flux
exogen
carbon
sourc
includ
glucos
glutamin
fatti
acid
amino
acid
complex
yet
wellcoordin
metabol
highway
sole
outcom
gener
energi
biomass
molecul
togeth
ensur
massiv
product
viru
particl
detail
account
import
subject
provid
recent
review
addit
emerg
common
viral
alter
cellular
metabol
also
worth
note
differ
virus
evolv
distinct
strategi
modul
cellular
metabol
support
viral
propag
even
close
relat
virus
two
herpesvirus
hcmv
manipul
cellular
metabol
pathway
elegantli
tailor
meet
differ
metabol
need
although
hcmv
alter
glycolysi
contrast
hcmv
increas
glucos
uptak
caus
aerob
glycolysi
divert
glucos
tca
cycl
drive
nucleotid
synthesi
support
rapid
viral
dna
replic
keep
pace
much
faster
viral
replic
cycl
h
compar
hcmv
h
metabolom
analysi
viral
alter
cellular
metabol
paint
rich
pictur
complex
fascin
metabol
interact
virus
host
deeper
understand
metabol
exchang
need
identif
underli
viral
mechan
includ
viral
gene
product
target
key
factor
specif
metabol
pathway
addit
worthwhil
elucid
step
viral
propag
benefit
viral
induc
chang
specif
metabol
pathway
exampl
although
kaposi
sarcomaassoci
herpesviru
kshv
alter
glycolysi
glutaminolysi
fatti
acid
synthesi
effici
viral
product
glycolysi
appear
support
transcript
earli
gene
glutaminolysi
need
translat
earli
gene
wherea
fatti
acid
synthesi
promot
late
step
product
extracellular
infecti
virion
detail
expect
guid
develop
drug
block
specif
metabol
process
key
propag
specif
pathogen
viru
yet
impos
margin
manag
side
effect
host
virus
modul
metabol
host
cell
host
also
develop
strategi
redirect
cellular
metabol
traffic
inhibit
viru
product
one
promin
host
mechan
interferon
type
interferon
ifn
discov
half
centuri
ago
strong
antivir
activ
influenza
viru
subsequ
studi
reveal
intric
signal
pathway
trigger
ifn
lead
express
hundr
gene
collect
call
interferonstimul
gene
isg
mani
shown
inhibit
varieti
virus
divers
mechan
isg
directli
target
impair
specif
step
viral
replic
exampl
ifitm
interferon
induc
transmembran
protein
deter
viral
entri
mx
myxoviru
resist
protein
recogn
viral
capsidnucleocapsid
imped
viral
genom
replic
tetherin
also
call
physic
link
viral
progeni
surfac
viral
produc
cell
thu
block
viru
releas
dissemin
furthermor
group
isg
inhibit
translat
viral
rna
thu
halt
viral
replic
isg
includ
pkr
protein
kinas
r
synthetas
oa
rnasel
zap
zinc
finger
antivir
protein
other
discuss
detail
recent
review
knowledg
antivir
function
isg
greatli
expand
sever
recent
investig
test
hundr
isg
inhibit
wide
rang
virus
addit
direct
inhibit
virus
isg
profession
viral
sensor
rigi
pkr
cga
other
beyond
function
mechan
emerg
new
antivir
strategi
employ
isg
modul
cellular
metabol
pathway
includ
synthesi
cholesterol
polyamin
tryptophan
cholesterol
abund
lipid
cell
membran
respons
membran
pack
fluiditi
replic
mani
virus
includ
viral
entri
viral
bud
affect
distribut
cholesterol
cellular
membran
thu
hinder
cholesterol
biosynthesi
inhibit
transcript
factor
name
sterol
regulatori
elementbind
protein
srebp
tightli
regul
biosynthesi
cholesterol
fatti
acid
regard
viral
infect
srebp
strongli
link
hcv
pathogenesi
wherebi
viru
upregul
srebp
activ
stimul
signal
consequ
antivir
mechan
employ
immun
respons
involv
transcript
downregul
attenu
viral
replic
quest
antivir
cellular
factor
target
sterol
pathway
came
discoveri
antivir
isg
encod
enzym
convert
cholesterol
solubl
oxysterol
potent
express
macrophag
dendrit
cell
respons
activ
tolllik
receptor
tlr
product
type
ii
ifn
figur
welldefin
role
regul
sterol
biosynthesi
reduc
cholesterol
accumul
thu
execut
antivir
cellular
function
may
also
repress
activ
andor
enhanc
express
microrna
regul
hepat
lipid
homeostasi
remain
fulli
elucid
cell
cultur
assay
shown
inhibit
multipl
envelop
virus
includ
hcv
vesicular
stomat
viru
vsv
ebola
viru
sft
viru
sftsv
west
nile
viru
wnv
dengu
viru
zika
viru
zikv
interestingli
pseudorabi
viru
prv
etiolog
agent
aujeszki
diseas
pig
despit
studi
report
inact
nonenvelop
virus
studi
shown
mark
antivir
activ
polio
viru
human
human
rotaviru
hrov
human
rhinoviru
hrhv
recent
studi
antivir
role
extend
beyond
human
viral
pathogen
investig
porcin
virus
even
role
nonmammalian
speci
zebrafish
interestingli
phylogenet
analysi
identifi
homolog
mammalian
zebrafish
howev
express
modul
type
ifn
nevertheless
studi
show
overexpress
protect
effect
zebrafish
larva
follow
spring
viremia
carp
viru
svcv
infect
support
result
mani
cell
cultur
base
assay
shown
suppress
infect
human
mice
recent
report
reduc
zika
viru
zikv
viremia
improv
surviv
mice
rhesu
monkey
attest
potenti
therapeut
valu
antivir
agent
exert
antivir
function
sever
mechan
figur
first
mechan
involv
alter
cellular
membran
composit
impact
multipl
stage
replic
differ
virus
rang
viral
entri
viral
genom
replic
viral
gene
express
cytoplasm
membran
structur
studi
conduct
liu
colleagu
demonstr
induc
cellular
membran
modif
result
impair
viral
entri
viruscel
fusion
specif
alter
cellular
membran
reduc
syncytia
format
inhibit
entri
without
affect
transcript
translat
bud
likewis
block
zikv
entri
cell
dosedepend
manner
inhibitori
role
hcv
infect
also
extens
studi
electron
microscopi
analysi
reveal
inhibit
format
membran
web
hcv
replic
site
intracellular
membran
second
mechan
antivir
action
work
posttransl
modif
ptm
glycosyl
common
ptm
occur
mani
viral
envelop
protein
shrivastavaranjan
colleagu
demonstr
inhibit
lassa
viru
lasv
arenaviru
caus
aberr
glycosyl
lasv
genom
consist
two
rna
segment
larg
l
small
small
segment
encod
glycoprotein
precursor
gpc
subsequ
cleav
mediat
viral
attach
host
cell
receptor
fusion
viral
endosom
membran
respect
nlink
glycosyl
critic
transport
site
viral
bud
carri
function
shrivastavaranjan
colleagu
show
impair
lasv
product
infect
inhibit
glycosyl
lead
incorpor
aberrantli
glycosyl
lasv
particl
precis
mechan
induc
chang
yet
elucid
add
multipl
antivir
mechan
one
studi
delv
relationship
immun
mechan
antivir
effect
cagno
colleagu
report
induct
promot
product
follow
viru
infect
nonenvelop
virus
polio
viru
exert
antivir
activ
interact
oxysterolbind
protein
osbp
osbp
sensor
coordin
andor
transport
cholesterol
er
golgi
experi
show
interfer
directli
transport
cholesterol
er
golgi
result
reduct
cholesterol
accumul
site
viral
replic
similarli
inhibit
replic
rhinovirus
bind
osbp
high
affin
lock
inact
state
evid
studi
sterol
pathway
includ
play
pivot
role
viral
infect
conserv
across
speci
nevertheless
host
attempt
downregul
lipid
uptak
manner
report
suggest
tlr
ifn
convers
increas
lipid
uptak
environ
lead
foam
cell
format
address
role
ifn
context
york
colleagu
found
tlr
type
ifn
decreas
de
novo
cholesterol
biosynthesi
yet
increas
cholesterol
uptak
surprisingli
metabol
shift
could
activ
type
ifn
signal
reveal
novel
ifnmedi
mechan
clearli
studi
warrant
determin
precis
molecular
interact
immun
respons
well
srebp
activ
develop
promis
drug
candid
polyamin
long
known
promot
replic
mani
dna
virus
rna
virus
yet
recent
report
ifn
modul
level
polyamin
consequ
suppress
life
cycl
polyaminedepend
virus
polyamin
ubiquit
small
posit
charg
biogen
molecul
essenti
promot
cell
growth
differenti
mediat
apoptosi
protect
cell
oxid
stress
three
mammalian
polyamin
deriv
ornithin
putrescin
spermidin
spermin
sever
ratelimit
enzym
determin
intracellular
level
polyamin
includ
ornithin
decarboxylas
odc
gener
putrescin
spermidinespermin
acetyltransferas
involv
regul
polyamin
concentr
via
catabol
spermin
back
spermidin
putrescin
figur
interestingli
express
respond
stimul
type
interferon
therefor
bona
fide
isg
owe
intens
posit
charg
polyamin
bind
dna
rna
cell
regul
function
nucleic
acid
alter
structur
conform
estim
polyamin
associ
cellular
rna
therefor
surpris
find
polyamin
virion
mani
dna
virus
includ
hcmv
vaccinia
viru
polyamin
neutral
neg
charg
viral
dna
genom
assist
packag
viral
dna
viru
particl
also
enhanc
viral
dna
synthesi
new
round
viral
replic
recent
studi
reveal
larg
number
rna
virus
also
depend
polyamin
replic
includ
semliki
forest
viru
chikungunya
viru
chikv
zikv
middl
east
respiratori
syndrom
coronaviru
merscov
enteroviru
ebola
viru
marburg
viru
mani
other
review
underli
mechan
includ
promot
synthesi
viral
rna
like
result
tight
bind
polyamin
viral
rna
acceler
viral
protein
translat
latter
mechan
action
stem
fact
spermidin
substrat
deoxyhypusin
synthas
key
enzym
account
hypusin
translat
initi
factor
recent
publish
polyamin
hypusin
shown
critic
ebola
viru
gene
express
replic
import
role
polyamin
viral
replic
support
result
studi
show
deplet
polyamin
use
difluoromethylornithin
dfmo
suicid
inhibitor
ratelimit
enzym
polyamin
synthesi
significantli
suppress
sindbi
viru
sinv
infect
drosophila
melanogast
zebrafish
danio
rerio
exploit
polyamin
virus
also
evid
light
viral
mechan
manipul
biosynthesi
polyamin
hcmv
adenoviru
vaccinia
viru
enhanc
activ
catalys
convers
ornithin
putrescin
polyamin
synthesi
pathway
paramecium
bursaria
chlorella
viru
even
encod
whole
polyamin
biosynthesi
pathway
includ
ornithinearginin
decarboxylas
homospermidin
synthas
agmatin
iminohydrolas
aih
ncarbamoylputrescin
amidohydrolas
cpa
suggest
import
putrescin
polyamin
life
cycl
meantim
hcv
appear
inhibit
synthesi
spermin
spermidin
putrescin
implic
viral
replic
need
investig
depend
mani
virus
polyamin
replic
evolut
inevit
endow
host
opportun
form
mechan
modul
polyamin
metabol
viral
replic
suppress
inde
recent
studi
show
treatment
lead
deplet
spermin
spermidin
concurr
increas
putrescin
result
induct
knockout
restor
putrescin
level
presenc
significantli
recov
infect
chikv
demonstr
deplet
polyamin
induct
repres
one
mechan
ifn
antivir
function
investig
regul
polyamin
pathway
interferon
viral
protein
andor
chang
cellular
environ
begin
uncov
multipl
pathway
crossprotect
current
target
polyamin
metabol
direct
toward
therapeuticprev
treatment
cancer
exampl
dfmo
irrevers
inhibitor
odc
recent
attract
interest
treatment
neuroblastoma
regard
treat
viral
infect
one
recent
studi
mice
show
polyamin
deplet
limit
chikv
replic
dfmo
stabl
welltoler
drug
mild
sideeffect
human
administ
via
sever
rout
includ
oral
mean
could
hold
promis
treat
viral
infect
ltryptophan
ltrp
discov
earli
one
nine
essenti
amino
acid
critic
sever
metabol
pathway
primarili
protein
kynurenin
serotonin
synthesi
least
abund
amino
acid
ltrp
catabolit
signific
role
diseas
toler
immunosuppress
importantli
kynurenin
pathway
account
greater
tryptophan
catabol
synthesi
kynurenin
kyn
deriv
tryptophan
initi
enzymat
activ
figur
isg
highli
express
across
mani
cell
type
wherea
mainli
express
hepatocyt
lower
affin
tryptophan
thu
significantli
import
tryptophan
homoeostasi
surprisingli
posit
intric
interfac
interact
first
host
cell
increas
express
respons
viral
infect
promot
region
gene
contain
two
interferonstimul
respons
element
isr
three
site
respond
interferon
often
produc
control
viral
infect
ifn
also
induc
express
remain
potent
induc
express
virus
metabol
inert
highli
suscept
ltrp
depriv
growth
rang
virus
inhibit
hiv
iav
hbv
hcv
vaccinia
viru
parainfluenza
viru
comprehens
screen
antiretrovir
isg
identifi
strong
activ
studi
subsequ
confirm
product
substanti
curtail
result
sever
suppress
viral
protein
synthesi
sinc
supplement
ltryptophan
inhibit
competit
inhibitor
fulli
rescu
hiv
product
cell
deplet
ltryptophan
block
viral
protein
synthesi
signific
role
strong
inhibit
product
demonstr
rescu
yield
tzmbl
cell
treat
either
ltryptophan
idoinhibitor
effort
screen
isg
inhibit
rabbani
colleagu
confirm
activ
ido
due
tryptophan
deplet
ad
exogen
tryptophan
inhibit
activ
ido
counteract
antivir
effect
ido
vitro
result
show
ad
tryptophan
concentr
higher
increas
amount
rescu
replic
rabbani
colleagu
investig
parallel
serotoninbiosynthet
pathway
initi
tryptophan
hydroxylas
tph
first
product
show
addit
idoexpress
cell
rescu
replic
addit
use
inhibitor
trp
hydroxylas
thp
group
show
provir
factor
longterm
induct
ido
express
lead
immunosuppress
sever
virus
use
advantag
promot
replic
gael
colleagu
studi
regul
kynurenin
pathway
iav
infect
previous
report
iav
induc
product
kynurenin
primari
macrophag
mous
lung
infect
iav
show
ifnmedi
upregul
howev
activ
attenu
iav
protein
suppress
interferon
product
addit
iav
virus
influenza
b
viru
also
lead
upregul
kynurenin
pathway
immun
cell
anoth
import
aspect
consid
role
serotonin
pathway
infect
clear
exampl
come
model
lymphocyt
choriomening
viru
lcmv
induc
hepat
lead
aggreg
activ
platelet
mice
platelet
secret
serotonin
liver
result
hepat
sinusoid
microcircul
failur
enhanc
tcell
cytotox
studi
provid
uniqu
perspect
role
serotonin
infect
permit
investig
immunosuppress
outcom
due
longterm
express
play
counterintuit
role
chronic
infect
ltrp
deplet
result
shift
immunotolerogen
microenviron
wherebi
increas
product
immunomodulatori
kynurenin
deriv
cell
respons
suppress
may
acceler
diseas
progress
recent
studi
use
sivinfect
pigtail
macaqu
model
also
report
evalu
kynurenin
pathway
metabolit
enzym
lymphoid
tissu
interestingli
result
show
signific
reduct
tryptophan
level
spleen
brain
despit
substanti
deplet
plasma
cerebrospin
fluid
csf
base
find
drew
colleagu
propos
tryptophan
deplet
primari
contributor
tcell
impair
hivsiv
infect
challeng
previou
report
regard
role
kynurenin
pathway
acut
chronic
viral
infect
warrant
research
import
subject
ifnmedi
upregul
upon
variou
acut
chronic
viral
infect
demonstr
mani
research
group
howev
doubleedg
sword
exert
antivir
effect
numer
virus
longterm
consequ
induct
could
contribut
diseas
progress
seen
promot
immunosuppress
environ
chronic
viral
infect
nonetheless
immunosuppress
natur
ido
could
use
advantag
promis
result
show
reduc
size
growth
tumor
mice
preimmun
tumor
antigen
regard
infect
earli
studi
demonstr
mice
treat
higher
cell
effector
memori
tcell
count
recent
studi
shown
suppress
ido
combin
natur
killer
cell
stimul
influenza
vaccin
boot
protect
immun
influenza
furthermor
mice
treat
infect
iav
elev
effector
memori
tcell
respons
lung
compar
control
group
group
also
show
increas
prr
proinflammatori
cytokin
upon
iav
infect
result
suggest
use
facilit
enhanc
immun
respons
infect
combin
adjuv
vaccin
nevertheless
one
cautiou
multipl
pathway
affect
upon
tryptophan
deplet
exact
mechan
remain
unknown
propag
larg
amount
viral
progeni
short
time
demand
synthesi
larg
quantiti
viral
genom
requir
adequ
suppli
nucleotid
substrat
cell
also
becom
weak
viral
replic
cell
abl
take
advantag
one
promin
exampl
cellular
antivir
strategi
along
line
steril
alpha
motif
histidineaspart
domain
contain
protein
inhibit
dna
synthesi
broad
rang
retrovirus
dna
virus
includ
murin
leukaemia
viru
mlv
human
cell
leukemia
viru
type
vaccinia
viru
hbv
prior
discoveri
antivir
factor
virus
gene
mutat
found
associ
autoimmun
neurolog
condit
syndrom
ag
ag
affect
newborn
infant
mimic
congenit
viral
infect
elev
level
cerebrospin
fluid
gene
first
identifi
human
dendrit
cell
ortholog
mous
gene
induc
upon
viral
infect
subsequ
studi
also
shown
type
type
ii
ifn
tolllik
agonist
upregul
express
multipl
cell
type
includ
murin
macrophag
pbmc
monocyt
microglia
interestingli
mrna
level
upregul
astrocyt
although
protein
level
remain
unchang
meantim
studi
also
report
monocytederiv
dendrit
cell
primari
cell
monocytederiv
macrophag
upregul
express
upon
interferon
treatment
inconsist
respons
interferon
stimul
partial
convent
isg
sens
promot
bear
classic
ifnrespond
dna
motif
rather
express
neg
control
coupl
microrna
mirna
includ
bind
untransl
region
utr
mrna
riess
colleagu
express
construct
contain
utr
cell
cell
demonstr
utr
requir
interferoninduc
express
group
also
show
mirna
neg
regul
express
name
support
induct
ifn
downregul
h
post
ifn
stimul
find
suggest
express
increas
interferon
decreas
dntp
hydrolas
regul
intracellular
dntp
level
catalys
convers
deoxynucleosid
triphosph
deoxynucleosid
inorgan
triphosph
thu
antivir
activ
deplet
pool
dntp
necessari
viral
dna
synthesi
viral
replic
certain
studi
also
suggest
rnase
activ
disput
result
group
studi
knockout
mice
show
signific
increas
intracellular
dntp
concentr
revers
transcript
retrovirus
whose
revers
transcriptas
low
affin
dntp
key
regul
cellular
dntp
pool
activ
subject
modul
cellular
viral
mechan
first
express
level
cell
cycl
depend
warrant
suffici
dntp
level
support
cellular
dna
duplic
phase
cyclindepend
kinas
part
mechan
control
cell
cycl
progress
phosphoryl
yet
defin
molecular
mechan
prevent
deplet
dntp
altern
cellular
mechan
involv
membran
protein
call
bind
interact
direct
toward
proteasom
degrad
side
virus
siv
encod
accessori
protein
call
vpx
recogn
recruit
ubiquitin
ligas
complex
ubiquitin
subsequ
proteasom
degrad
intrigu
much
success
pathogen
caus
global
hiv
pandem
last
decad
alreadi
bother
form
mechan
counter
among
possibl
explan
one
high
level
rest
cell
impair
synthesi
dna
abort
viral
dna
fragment
trigger
pyropoptosi
activ
dna
sensor
lead
deplet
cell
addit
inhibit
infect
dc
delay
sens
infect
onset
immun
respons
consequ
leav
viru
longer
time
window
establish
local
infect
foot
hold
later
system
infect
viral
infect
remain
signific
challeng
human
health
rang
season
outbreak
influenza
affect
global
popul
recent
outbreak
zika
viru
dengu
viru
ebola
viru
middl
east
respiratori
syndrom
coronaviru
merscov
due
appear
new
emerg
reemerg
virus
given
fact
mani
antivir
highli
specif
viral
target
clear
need
develop
new
drug
find
novel
therapeut
target
viral
infect
specif
broadspectrum
ie
pangenotyp
panfamili
antivir
drug
access
afford
low
incom
countri
virus
metabol
engin
dramat
affect
host
cell
metabol
viru
life
cycl
provid
novel
avenu
therapeut
intervent
prime
exampl
iav
iav
evolv
continu
caus
pneumonia
enceph
myocard
even
multipl
organ
failur
death
antivir
drug
target
viral
factor
avail
howev
studi
shown
rise
viral
resist
neuraminidas
inhibitor
smallwood
colleagu
recent
identifi
metabol
chang
iavinfect
human
lung
epitheli
cell
chang
observ
pediatr
patient
infect
respiratori
viral
infect
includ
increas
glucos
glutamin
uptak
fatti
acid
metabol
tca
cycl
oxid
phosphoryl
compar
noninfect
patient
moreov
conduct
target
drug
screen
metabol
drug
smallwood
colleagu
identifi
drug
reduc
viral
titer
vitro
vivo
significantli
increas
surviv
mice
revers
influenzainduc
metabol
chang
inhibitor
mtor
metabol
pathway
current
drug
candid
clinic
trial
treatment
cancer
thought
exert
antivir
effect
limit
avail
glucos
glutamin
iav
much
work
yet
conduct
understand
mechan
behind
antivir
effect
longterm
consequ
given
similar
metabol
profil
cancer
cell
viru
infect
cell
may
come
surpris
drug
candid
use
treatment
cancer
shown
effect
control
pathogen
virus
anoth
exampl
came
detail
analysi
metabol
chang
primari
hepatocyt
upon
hcv
infect
agreement
other
levi
colleagu
demonstr
hcvinfect
primari
hepatocyt
underw
warburglik
shift
glycolysi
downregul
oxid
phosphoryl
importantli
concomit
transcript
regulatori
analysi
glycolysi
identifi
enrich
two
nuclear
receptor
key
regul
lipid
homeostasi
gluconeogenesi
well
cell
prolifer
apoptosi
support
find
addit
antagonist
sirna
reduc
glycolysi
significantli
decreas
lactat
product
addit
upon
addit
antagonist
three
fourfold
decreas
viral
rna
level
observ
studi
support
concept
revers
metabol
chang
caus
virus
use
chemic
compound
may
serv
attract
therapeut
strategi
control
viral
infect
fatti
acid
cholesterol
synthesi
enhanc
upon
viral
infect
support
gener
new
viral
progeni
come
surpris
monophosphateactiv
protein
kinas
ampk
also
activ
ampk
intracellular
sensor
maintain
metabol
homeostasi
regul
glucos
lipid
metabol
activ
ampk
inhibit
fatti
acid
cholesterol
synthesi
upregul
fatti
acid
oxid
dysregul
ampk
implic
metabol
syndromerel
diseas
studi
shown
activ
ampk
restrict
number
rna
virus
includ
rift
valley
fever
viru
rvfv
bunyaviru
sinv
vsv
recent
paper
investig
ampk
activ
respons
kshv
primari
infect
result
show
inhibit
ampk
significantli
enhanc
kshv
lytic
replic
given
import
ampk
cellular
metabol
multipl
drug
develop
treat
metabol
disord
one
drug
ribonucleotid
aicar
amp
analog
stimul
ampk
activ
studi
conduct
use
aicar
treat
ischemia
type
ii
diabet
shown
promis
regard
viral
infect
group
observ
inhibit
kshv
lytic
gene
upon
aicar
treatment
correspond
suppress
lytic
replic
furthermor
metformin
firstlin
drug
manag
type
ii
diabet
also
decreas
viral
yield
also
inhibit
activ
kshv
lytic
gene
overal
result
suggest
ampk
could
use
therapeut
target
treat
viral
infect
howev
ampk
evolutionari
conserv
kinas
pivot
role
multipl
signal
pathway
prolong
activ
could
unwant
consequ
virusspecif
effect
ampk
also
warrant
care
test
ampk
inhibitor
individu
virus
need
cautiou
virus
may
still
escap
treatment
target
cellular
factor
pathway
recent
publish
paper
aim
address
issu
antivir
resist
compound
target
polyamin
synthesi
use
potenti
treatment
prolong
viru
passag
cell
treat
drug
difluoromethylornithin
dfmo
result
product
chikv
mutant
resist
polyamin
deplet
vitro
sequenc
analysi
viral
popul
identifi
three
distinct
mutat
nonstructur
protein
chang
opal
stop
codon
arginin
interestingli
individu
express
mutat
confer
resist
polyamin
deplet
howev
vitro
vivo
studi
reveal
combin
mutat
enhanc
chikv
replic
fit
allow
viru
resist
dmfo
treatment
immunoprecipit
studi
two
mutat
enhanc
membran
bind
promot
genom
methyl
mutat
opal
sop
codon
enhanc
downstream
translat
result
highlight
strategi
chikv
develop
surviv
polyamin
deplet
select
mutat
elev
viral
fit
target
host
cell
metabol
provid
uniqu
opportun
restrict
viral
propag
one
need
consid
potenti
neg
effect
immun
cell
function
particular
viru
infect
cell
activ
immun
cell
tend
adopt
aerob
glycolysi
gener
suffici
amount
energi
macromolecul
rel
short
time
period
support
rapid
viru
replic
cell
prolifer
therefor
select
target
cell
metabol
step
key
effect
success
antivir
therapi
inhibit
viral
propag
immun
cell
function
virus
evolv
mechan
target
host
metabol
network
ensur
surviv
simultan
host
accordingli
select
distinct
antivir
mechan
counteract
chang
innat
immun
respons
play
pivot
role
respond
viral
chang
effort
warrant
cell
surviv
limit
viral
propag
robust
ifn
respons
lead
prime
adapt
immun
respons
modul
metabol
pathway
innat
immun
cell
macrophag
dc
well
induct
isg
restrict
factor
interfer
cellular
metabol
sever
isg
exert
antivir
activ
multipl
virus
includ
denv
zikv
hcv
hsv
target
differ
metabol
pathway
current
limit
number
isg
report
modul
cellular
metabol
futur
studi
includ
gene
express
pathway
analysi
interferom
databas
could
potenti
lead
discoveri
isg
link
metabol
role
ifn
isg
immunometabol
regul
carbon
metabol
open
novel
avenu
viral
therapi
develop
massspectrometri
gene
express
screen
led
deeper
understand
virushost
metabol
interact
howev
much
remain
discov
regard
detail
molecular
mechan
metabol
interact
potenti
clinic
applic
import
note
target
metabol
pathway
therapeut
intervent
may
lead
fit
cost
host
howev
potenti
side
effect
shortterm
manag
seen
mani
medic
target
cellular
compon
interf
certain
pathway
may
overal
benefici
may
lead
product
broad
spectrum
antivir
